Today: 14 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Chip Stocks Roar Back: Why SMH, SOXX, EWT, EWY And Eaton Are Back In Focus

Chip Stocks Roar Back: Why SMH, SOXX, EWT, EWY And Eaton Are Back In Focus

The Philadelphia Semiconductor Index jumped nearly 5% Friday, driving AI-linked ETFs higher and sending the S&P 500 and Nasdaq to record closes. Nvidia advanced, while Micron and Sandisk rallied about 12%. Taiwan and South Korea chip ETFs also gained, with EWY up 7.4%. Eaton reported Q1 sales of $7.5 billion, up 17%, and raised its 2026 growth outlook.
Dow Jones Today: Blue-Chip Index Barely Rises as AI Rally Sends Nasdaq, S&P 500 to Records

Dow Jones Today: Blue-Chip Index Barely Rises as AI Rally Sends Nasdaq, S&P 500 to Records

The Dow Jones Industrial Average closed nearly flat Friday, up 0.02% to 49,609.16, while the S&P 500 rose 0.84% and the Nasdaq jumped 1.71% as tech shares outperformed. U.S. nonfarm payrolls increased by 115,000 in April and unemployment held at 4.3%. Nvidia gained 1.8%, and Micron and Sandisk surged about 12%. Consumer sentiment fell in May, with inflation expectations easing slightly.
US Stock Market Today After the Bell: S&P 500, Nasdaq Hit Records as AI Rally Runs Past Oil Risks

US Stock Market Today After the Bell: S&P 500, Nasdaq Hit Records as AI Rally Runs Past Oil Risks

The S&P 500 and Nasdaq closed at record highs Friday, boosted by AI chip stocks and a stronger-than-expected April jobs report showing 115,000 new nonfarm jobs and 4.3% unemployment. Nvidia rose 1.8%, Micron and Sandisk jumped about 12%. The Philadelphia semiconductor index gained nearly 5%. Six of 11 S&P 500 sectors fell, and market breadth remained mixed.
Hims Stock Faces 15% Earnings Swing as Weight-Loss Pivot Comes Due

Hims Stock Faces 15% Earnings Swing as Weight-Loss Pivot Comes Due

Hims & Hers Health shares jumped 9.3% to $28.03 Friday as options traders bet on a 14.8% swing after next week’s earnings. The company will report first-quarter results after markets close May 11. Analysts remain divided, with price targets ranging from $25 to $32. Hims recently launched a compounded testosterone pill and an AI lab-results tool, and expanded access to FDA-approved weight-loss drugs.
Prospect Capital Stock Slides After Earnings as Dividend Reset Hits Focus

Prospect Capital Stock Slides After Earnings as Dividend Reset Hits Focus

Prospect Capital shares dropped 9.6% Friday after the company reported lower March-quarter net investment income and cut its monthly common distribution to $0.035 per share for May through August. The stock traded near $2.49, well below its March 31 net asset value of $6.05. Net investment income fell to $78.5 million, or $0.16 per share, and total assets declined to $6.38 billion.
DXC Technology Stock Plunges After Earnings as 2027 Outlook Clouds AI Turnaround

DXC Technology Stock Plunges After Earnings as 2027 Outlook Clouds AI Turnaround

DXC Technology shares fell 23% to $9.20 after forecasting another year of organic revenue declines and reporting a GAAP loss of 84 cents per share for the fiscal fourth quarter. Revenue dropped 1.2% to $3.13 billion, with organic revenue down 6.6%. Bookings fell 14% from a year earlier. Management cited weak demand for short-term project work, especially in Global Infrastructure Services.
Main Street Capital Stock Drops After Q1 Earnings Miss as Dividend Story Faces a Test

Main Street Capital Stock Drops After Q1 Earnings Miss as Dividend Story Faces a Test

Main Street Capital shares fell 4.5% to $54.05 after first-quarter net investment income missed forecasts, coming in at $0.93 per share versus the $1.04 estimate. Total investment income was $140.1 million, below the $146.14 million expected. Net asset value rose slightly to $33.46 per share. The company declared regular monthly dividends totaling $0.78 per share for the second quarter.
Moderna Stock Surges on Hantavirus Vaccine News as Cruise Outbreak Puts mRNA Pipeline Back in Focus

Moderna Stock Surges on Hantavirus Vaccine News as Cruise Outbreak Puts mRNA Pipeline Back in Focus

Moderna shares rose about 10% Friday after the company announced research into vaccines for hantaviruses amid a deadly Andes virus outbreak linked to the MV Hondius cruise ship. WHO reported eight cases and three deaths, with five confirmed as hantavirus. Moderna’s vaccine program is in early stages, with commercial availability still years away. The U.S. is arranging a repatriation flight for 17 Americans from the ship.
Wynn Resorts Stock Falls Despite Q1 Beat as UAE Delay Clouds a Big Macau Bet

Wynn Resorts Stock Falls Despite Q1 Beat as UAE Delay Clouds a Big Macau Bet

Wynn Resorts shares fell $7.21 to $99.64 Friday despite beating first-quarter profit estimates, as investors reacted to a delayed UAE resort timeline and a new $900 million-plus expansion at Wynn Palace in Macau. Operating revenue rose 9.2% to $1.86 billion and adjusted profit reached $1.25 a share, topping forecasts. Wynn Palace revenue jumped 23% to $659.3 million. Construction on the new Macau tower starts in late 2026.
MaxLinear Stock Nears $100 as AI Data-Center Rally Sets Up a Shareholder Test

MaxLinear Stock Nears $100 as AI Data-Center Rally Sets Up a Shareholder Test

MaxLinear shares jumped over 21% to $101.20 Friday, pushing the company’s market value to about $8.8 billion ahead of a May 20 shareholder vote on expanding its equity incentive plan. The rally followed first-quarter revenue of $137.2 million, up 43% year-over-year, driven by demand for optical products in AI data centers. Glass Lewis backed the equity plan; ISS opposed it.
Why Arbor Realty Trust Stock Is Falling: Dividend Cut, Weak Q1 Earnings Put ABR Loan Book in Focus

Why Arbor Realty Trust Stock Is Falling: Dividend Cut, Weak Q1 Earnings Put ABR Loan Book in Focus

Arbor Realty Trust cut its quarterly dividend to $0.17 from $0.30 after reporting net income of $629,000, down from $30.4 million a year earlier. Shares dropped about 11% to $7.29 as investors reacted to ongoing loan troubles and property takebacks. Non-performing assets totaled about $1 billion at quarter-end, with management warning that higher rates could slow asset resolutions.
Dell Stock Soars as AI Server Boom, TotalEnergies Deal and Super Micro Trouble Collide

Dell Stock Soars as AI Server Boom, TotalEnergies Deal and Super Micro Trouble Collide

Dell shares rose 12.6% Friday, reaching $263.82 intraday, after news of a $100 million supercomputer contract with TotalEnergies and Nvidia and renewed focus on rival Super Micro’s legal issues. Investors shifted attention to Dell’s AI-server business, with the company reporting over $64 billion in AI-optimized server orders for fiscal 2026. Dell’s fiscal first-quarter results are due May 28.
Novavax Stock Jumps As Pfizer Deal Cash Puts Vaccine Turnaround Back In Focus

Novavax Stock Jumps As Pfizer Deal Cash Puts Vaccine Turnaround Back In Focus

Novavax shares jumped 13% Friday after first-quarter revenue reached $139.5 million, beating estimates. Licensing and partner payments, including $30 million from Pfizer’s Matrix-M deal, offset weak COVID-19 vaccine demand. The stock traded at $10.45 with volume over 8.4 million shares. Investors await the company’s appearance at BofA’s health-care conference on May 13.
POET Technologies Stock Rebounds as Marvell Fallout Turns Into a June Lawsuit Deadline

POET Technologies Stock Rebounds as Marvell Fallout Turns Into a June Lawsuit Deadline

POET Technologies shares rose Friday, climbing $1.39 to $10.97, despite new shareholder notices tied to a securities class action over its U.S. tax disclosures and cancelled Celestial AI orders. The lawsuit, filed April 28 in New Jersey federal court, names POET, CFO Thomas Mika, and CEO Suresh Venkatesan as defendants. Investors have until June 29 to seek lead plaintiff status for the proposed class.
nLIGHT Stock Jumps as Defense Laser Sales Drive 55% Revenue Surge

nLIGHT Stock Jumps as Defense Laser Sales Drive 55% Revenue Surge

nLIGHT Inc shares jumped 10.3% to $72.98 Friday after reporting a 55.2% surge in Q1 revenue to $80.2 million and a swing to a $645,000 profit, driven by record defense sales. Aerospace and defense accounted for $55.1 million, or nearly 69% of total revenue. The company launched its HADES high-energy laser system for military use. Cash holdings rose to $298.2 million after a February stock offering.
Traws Pharma Stock Jumps As Biotech Targets Hantavirus After Cruise Ship Deaths

Traws Pharma Stock Jumps As Biotech Targets Hantavirus After Cruise Ship Deaths

Traws Pharma said it will advance clinical candidates for hantavirus after a cruise-ship outbreak killed three people, with no lead drug named yet. WHO confirmed five hantavirus cases on the MV Hondius, three fatal, and said person-to-person spread is limited. Traws shares jumped 21.8% after the announcement. The company has no approved products and recently raised $10 million in private funding.
SanDisk Stock Bounced Back Fast—Here’s Why Wall Street Is Still Chasing AI Memory

SanDisk Stock Bounced Back Fast—Here’s Why Wall Street Is Still Chasing AI Memory

Sandisk shares surged 11.7% to $1,497 Friday, rebounding from a sharp drop after concerns over short-term NAND demand. The company reported third-quarter revenue up 251% year-over-year to $5.95 billion and signed contracts guaranteeing $42 billion in future revenue. Investors cited ongoing tight supply for AI memory chips. The stock touched an intraday high of $1,528.
OPEN Stock Drops as Opendoor’s Bigger Q1 Loss Tests Turnaround Hopes

OPEN Stock Drops as Opendoor’s Bigger Q1 Loss Tests Turnaround Hopes

Opendoor Technologies shares fell 4.5% to $5.08 after reporting a first-quarter net loss of $173 million, wider than last year, despite revenue of $720 million topping analyst estimates. The company doubled acquisition contracts to over 5,000 and cut stale inventory, but homes sold dropped to 1,921. General and administrative expenses jumped $104 million, mainly from equity pay. Opendoor forecast Q2 revenue up 25% and adjusted EBITDA near breakeven.
1 17 18 19 20 21 808

Stock Market Today

  • ICG Enterprise Trust buys back 125,000 shares at 1390p each
    May 14, 2026, 2:55 AM EDT. ICG Enterprise Trust Plc repurchased 125,000 of its own shares on 13 May 2026 at an average price of 1390 pence per share. These shares will be held as treasury shares, increasing total treasury holdings to 2,485,221. The total shares in issue, excluding treasury shares, now stand at 61,068,971. This buyback was executed under authority granted at the June 2025 Annual General Meeting, which allows repurchases up to 14.99% of ordinary shares. The company, using Numis Securities Limited as broker, intends to hold these shares in treasury. No premium above net asset value was paid, adhering to regulatory and shareholder guidelines.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 14.05.2026

14 May 2026
LIVEMarkets rolling coverageStarted: May 14, 2026, 12:00 AM EDTUpdated: May 14, 2026, 3:04 AM EDT ICG Enterprise Trust buys back 125,000 shares at 1390p each May 14, 2026, 2:55 AM EDT. ICG Enterprise Trust Plc repurchased 125,000 of its own shares on 13 May 2026 at an average price of 1390 pence per share. These shares will be held as treasury shares, increasing total treasury holdings to 2,485,221. The total shares in issue, excluding treasury shares, now stand at 61,068,971. This buyback was executed under authority granted at the June 2025 Annual General Meeting, which allows repurchases up to 14.99%
Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
Go toTop